Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

St. Jude Medical Tags Device Tax As Acquisition Opportunity-Maker

This article was originally published in The Gray Sheet

Executive Summary

The company is maintaining reserves so it can move forward with beneficial acquisition opportunities as they arise, opportunities that St. Jude executives think might become more frequent next year with the 2.3% device tax in place.

You may also be interested in...



Most Companies Still Mum On Device Tax Coping Strategies

While some companies have started to reveal strategies to either soften the blow or to capitalize on the impending device excise tax, many have revealed little to no detail on their planned response.

Everything-But-CRM Growth Drivers Slow In Q2 For St. Jude

Amid a persistently contracting cardiac rhythm management market, the firm’s CRM business, while not growing, performed better than expected in the second quarter. But several of it its non-CRM businesses, which the company relies on to drive growth, experienced a slowdown.

First Device Tax Deposits Due Next January

Although medical device taxes will need to be paid quarterly, the first deposits are due soon after the tax takes effect next January, KPMG tax experts say.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031416

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel